asthma
Item
a diagnosed history of asthma for at least 6 months
boolean
C0004096 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
mild stable asthma only using β2-agonists
Item
mild and stable asthma, only using β2-agonists as needed for the last 4 weeks.
boolean
C0741266 (UMLS CUI [1,1])
C2945599 (UMLS CUI [1,2])
C2936789 (UMLS CUI [2])
fev1 post-bronchodilator
Item
fev1 >70% of predicted normal value (post-bronchodilator value).
boolean
C0748133 (UMLS CUI [1,1])
C2599594 (UMLS CUI [1,2])
skin prick test positive to pollen, animal dander or house dust mite
Item
skin prick test positive to pollen, animal dander or house dust mite.
boolean
C0430561 (UMLS CUI [1,1])
C0323138 (UMLS CUI [1,2])
C0440454 (UMLS CUI [1,3])
C3539110 (UMLS CUI [1,4])
respiratory disease
Item
any significant respiratory disease, other than asthma.
boolean
C0035204 (UMLS CUI [1])
respiratory tract infection
Item
upper or lower respiratory tract infection within 4 weeks before inclusion.
boolean
C0035243 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
use of
Item
use of:
boolean
C1524063 (UMLS CUI [1])
inhaled steroid treatment
Item
1. inhaled glucocorticosteroid treatment for the last 8 weeks prior to inclusion or ever used oral glucocorticoid treatment for asthma.
boolean
C0001617 (UMLS CUI [1,1])
C0556393 (UMLS CUI [1,2])
C0006280 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes
Item
2. inhaled long-acting or oral b2-agonists, anticholinergic bronchodilators, cromones, antihistamines, theophyllines and anti-leukotrienes within 2 weeks of screening.
boolean
C2936789 (UMLS CUI [1])
C0354764 (UMLS CUI [2])
C0019590 (UMLS CUI [3])
C0039771 (UMLS CUI [4])
nsaids
Item
3. regular nsaids
boolean
C0003211 (UMLS CUI [1])